Overview of Some Risk Factors in Cardiovascular Disease

Abstract

Much more specialists are nowadays aligning themselves on the view according to which the prevalence of cardiovascular disease will reach epidemic levels in the near future due to the increase of hypertension, diabetes and obesity. Most epidemiological studies indicate that we are confronted with a multiplication of risk factors, with an emphasis on their genetic conditioning as well as an acceleration of the effects generated by non-genetic factors. According to WHO recommendations, the appropriate methods of reducing the cardiovascular risk are those that combine health policies with efficient education measures. Long-term results of these measures aim to decrease the incidence of complications and associated costs with their treatment at the same time with increasing the quality of life. Approximately 50% of deaths from heart disease could be prevented through sustained action on the main cause-hypertension-and by treating risk factors, primarily hyperlipidemia and elevated body weight. Atherosclerotic disease requires a rigorous approach because identifying predisposing risk factors with proven implications in the initiation and progression of this disease, as well as modulation of those with protective role, can have a significant impact in finding an appropriate treatment in order to improve cardiovascular diseases and their consequences.

The Need for Clearance in Relaxation Therapy: Development of the Relaxation Clearance Tool for Practitioners

“…The person with this condition may not have stabilised sugar levels if the condition is not medically managed well [15,16]. Diabetes is also one of the biomarkers of a cardiovascular disease [15,16]. Sugar levels may go low and might not support the strong tensing of muscle groups as in Progressive Muscle Relaxation [15,16].…”

“…The person with this condition may not have stabilised sugar levels if the condition is not medically managed well [15,16]. Diabetes is also one of the biomarkers of a cardiovascular disease [15,16].…”

“…This causes the heart muscles to become weaker. Holding on breaths may cause pains in the chest area and raise the blood pressure [15,16]. People with cardiovascular conditions should not perform Progressive Muscle relaxation which involves holding on breaths.…”

“…Diabetes is also one of the biomarkers of a cardiovascular disease [15,16]. Sugar levels may go low and might not support the strong tensing of muscle groups as in Progressive Muscle Relaxation [15,16].…”

“…Although treatment involving relaxation is noninvasive with little or no side-effects [2,5,6], it is necessary to screen clients before they undergo relaxation therapy. Screening before relaxation therapy is very important because some medical [15,16] and mental conditions suffered by the client may prevent him/her from safely going through some aspects of the Relaxation Treatment Procedure [17][18][19]. Screening before relaxation therapy is therefore very necessary.…”